Effect Of Empagliflozin (Empa) On Anthropometry And Markers Of Visceral And Total Adiposity By Age, Sex, And Degree Of Abdominal Obesity In Patients With Type 2 Diabetes (T2d) And Cardiovascular Disease (Cvd): Empa-Reg Outcome
DIABETES（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要